Epicardial fat (epicardial adipose tissue, EAT) has been implicated in the pathogenesis of coronary artery disease (CAD). The objective of this study was to examine the relationship between EAT and generalized obesity, central or visceral adipose tissue (VAT), and the components of the metabolic syndrome—systolic blood pressure (SBP), triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), and fasting blood glucose (FBG)—that are linked to CAD. A systematic review of the literature, following meta-analysis guidelines, was conducted until May, 2013, using the search strategy “Obesity” OR “abdominal obesity” OR “metabolic syndrome” OR “metabolic syndrome X” AND “epicardial fat”. Thirty-eight studies fulfilled the criteria. There was a highly significant (P<0.00001) correlation between EAT and body mass index (BMI), waist circumference (WC), or VAT. The correlation between EAT and VAT was significantly (P<0.0001) greater than the correlation between EAT and WC, which in turn was significantly greater than the correlation between EAT and BMI. Overall, EAT was 7.5±0.1 mm in thickness in the metabolic syndrome (n=427) compared to 4.0±0.1 mm in controls (n=301). EAT correlated significantly (P<0.0001) with SBP, TGs, HDL, and FBG, but the strength of the association was less than one-half of the relationship of EAT to indices of obesity. The results of multivariate analysis were less consistent but show a relationship between EAT and metabolic syndrome independent of BMI. In summary, the very strong correlation between EAT and VAT suggests a relationship between these two adipose tissue depots. Measurement of EAT can be useful to indicate VAT. Whereas EAT correlates significantly with each of the components of the metabolic syndrome— SBP, TGs, HDL, or FBG—the magnitude of the relationship is considerably and significantly less than the relationship of EAT to BMI. These data show the strong relationship between EAT and BMI but especially with WC and VAT. They also demonstrate the smaller magnitude of the association of EAT with standard coronary risk factors, related to the metabolic syndrome, and suggest that the unique features of this adipose tissue warrant detailed investigation.
Get full access to this article
View all access options for this article.
References
1.
RabkinSW, MathewsonFA, HsuPH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: The Manitoba Study. Am J Cardiol, 1977; 39:452–458.
2.
RabkinSW. Epicardial fat: Properties, function and relationship to obesity. Obes Rev, 2007; 8:253–261.
3.
XuY, ChengX, HongK, HuangC, et al.How to interpret epicardial adipose tissue as a cause of coronary artery disease: A meta-analysis. Coron Artery Dis, 2012; 23:227–233.
LandsbergL, AronneLJ, BeilinLJ, et al.Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment: A position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens, 2013; 15:14–33.
6.
SubramanianS, ChaitA. Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta, 2012; 1821:819–825.
7.
HaasMJ, MooradianAD. Regulation of high-density lipoprotein by inflammatory cytokines: Establishing links between immune dysfunction and cardiovascular disease. Diabetes Metab Res Rev, 2010; 26:90–99.
8.
AlbertiKG, EckelRH, GrundySM, et al.International Diabetes Federation Task Force on Epidemiology and Prevention. Hational Heart and Blood Institute.American Heart Association.Wor L. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation, 2009; 120:1640–1645.
9.
GrundySM, CleemanJI, DanielsSR, et al.American Heart Association. National Heart and Blood Institute L. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 2005; 112:2735–2752.
10.
MottilloS, FilionKB, GenestJ, et al.The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol, 2010; 56:1113–1132.
11.
GalassiA, ReynoldsK, HeJ. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med, 2006; 119:812–819.
12.
StroupDF, BerlinJA, MortonSC, et al.Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA, 2000; 283:2008–2012.
13.
MoherD, LiberatiA, TetzlaffJ, et al.Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol, 2009; 62:1006–1012.
14.
FieldAP. Meta-analysis of correlation coefficients: A Monte Carlo comparison of fixed- and random-effects methods. Psychol Methods, 2001; 6:161–180.
15.
BettencourtN, ToschkeAM, LeiteD, et al.Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol, 2012; 158:26–32.
16.
KimM-K, TanakaK, KimM-J, et al.Epicardial fat tissue: Relationship with cardiorespiratory fitness in men. Med Sci Sports Exerc, 2010; 42:463–469.
17.
LaiY-H, YunC-H, YangF-S, et al.Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: A study validated with computed tomography. J Am Soc Echocardiogr, 2012; 25:234–241.
18.
GaboritB, JacquierA, KoberF, et al.Effects of bariatric surgery on cardiac ectopic fat: Lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol, 2012; 60:1381–1389.
19.
GranerM, SirenR, NymanK, et al.Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab, 2013; 98:1189–1197.
20.
BorruelS, Fernandez-DuranE, AlpanesM, et al.Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab, 2013; 98:1254–1263.
21.
KilicaslanB, OzdoganO, AydinM, et al.Increased epicardial fat thickness is associated with cardiac functional changes in healthy women. Tohoku J Exp Med, 2012; 228:119–124.
22.
CavalcanteJL, TamarappooBK, HachamovitchR, et al.Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction. Am J Cardiol, 2012; 110:1793–1798.
23.
SironiAM, PetzR, De MarchiD, et al.Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med, 2012; 29:622–627.
24.
GranerM, Seppala-LindroosA, RissanenA, et al.Epicardial fat, cardiac dimensions, and low-grade inflammation in young adult monozygotic twins discordant for obesity. American J Cardiol, 2012; 109:1295–1302.
25.
GaboritB, KoberF, JacquierA, et al.Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: Relationship to metabolic profile, cardiac function and visceral fat. Int J Obes, 2012; 36:422–430.
26.
YerramasuA, DeyD, VenurajuS, et al.Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis, 2012; 220:223–230.
27.
KaradagB, OzuluB, OzturkFY, et al.Comparison of epicardial adipose tissue (EAT) thickness and anthropometric measurements in metabolic syndrome (MS) cases above and under the age of 65. Arch Gerontol Geriatr, 2011; 52:e79–e84.
28.
IacobellisG, LonnE, LamyA, et al.Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol, 2011; 146:452–454.
29.
SicariR, SironiAM, PetzR, et al.Pericardial rather than epicardial fat is a cardiometabolic risk marker: An MRI vs echo study. J Am Soc Echocardiogr, 2011; 24:1156–1162.
30.
MalavazosAE, Di LeoG, SecchiF, et al.Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol, 2010; 105:1831–1835.
31.
AydinH, ToprakA, DeyneliO, et al.Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab Syndr Relat Disord, 2010; 8:229–234.
32.
WangTD, LeeWJ, ShihFY, et al.Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat. J Clin Endocrinol Metab, 2009; 94:662–669.
33.
OkyayK, BalciogluAS, TavilY, et al.A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome. Int J Cardiovasc Imaging, 2008; 24:577–583.
34.
IacobellisG, PellicelliAM, GrisorioB, et al.Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat. Obesity (Silver Spring), 2008; 16:179–183.
35.
IacobellisG, LeonettiF. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab, 2005; 90:6300–6302.
36.
IacobellisG, RibaudoMC, AssaelF, et al.Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: A new indicator of cardiovascular risk. J Clin Endocrinol Metab, 2003; 88:5163–5168.
37.
NakazatoR, RajaniR, ChengVY, et al.Weight change modulates epicardial fat burden: A 4-year serial study with non-contrast computed tomography. Atherosclerosis, 2012; 220:139–144.
38.
FuC-P, SheuWH-H, LeeI-T, et al.Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. Clin Chim Act, 2013; 421:98–103.
39.
SironiAM, PetzR, De MarchiD, et al.Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med, 2012; 29:622–627.
40.
GaboritB, JacquierA, KoberF, et al.Effects of bariatric surgery on cardiac ectopic fat: Lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol, 2012; 60:1381–1389.
41.
StramagliaG, GrecoA, GuglielmiG, et al.Echocardiography and dual-energy x-ray absorptiometry in the elderly patients with metabolic syndrome: A comparison of two different tecniques to evaluate visceral fat distribution. J NutrHealth Aging, 2010; 14:6–10.
42.
MalavazosAE, ErmeticiF, CeredaE, et al.Epicardial fat thickness: Relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity. Nutr Metab Cardiovasc Dis, 2008; 18:523–530.
43.
AlbertiKG, ZimmetP, ShawJ. IDF Epidemiology Task Force Consensus G. The metabolic syndrome—a new worldwide definition. Lancet, 2005; 366:1059–1062.
44.
YorgunH, CanpolatU, HazirolanT, et al.Increased epicardial fat tissue is a marker of metabolic syndrome in adult patients. Int J Cardiol, 2013; 165:308–313.
45.
SengulC, DumanD. The association of epicardial fat thickness with blunted heart rate recovery in patients with metabolic syndrome. Tohoku J Exp Med, 2011; 224:257–262.
46.
PierdomenicoSD, PierdomenicoAM, NeriM, et al.Epicardial adipose tissue and metabolic syndrome in hypertensive patients with normal body weight and waist circumference. Am J Hypertens, 2011; 24:1145–1149.
47.
IacobellisG, WillensHJ, BarbaroG, et al.Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring), 2008; 16:887–892.
48.
TokD, CagliK, KadifeI, et al.Impaired coronary flow reserve is associated with increased echocardiographic epicardial fat thickness in metabolic syndrome patients. Coron Artery Dis, 2013; 24:191–195.
49.
LiangKW, TsaiIC, LeeWJ, et al.MRI measured epicardial adipose tissue thickness at the right AV groove differentiates inflammatory status in obese men with metabolic syndrome. Obesity, 2012; 20:525–532.
50.
WangCP, HsuHL, HungWC, et al.Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Eendocrinol, 2009; 70:876–882.
51.
OkyayK, BalciogluAS, TavilY, et al.A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome. Int J Cardiovasc Imaging, 2008; 24:577–583.
52.
KerrJD, HoldenRM, MortonAR, et al.Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3–5 chronic kidney disease. BMC Nephrol, 2013; 14:26–30.
53.
De VosAM, ProkopM, RoosCJ, et al.Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J, 2008; 29:777–783.
54.
WillensHJ, ByersP, ChirinosJA, et al.Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol, 2007; 99:1242–1245.
55.
MarchingtonJM, MattacksCA, PondCM. Adipose tissue in the mammalian heart and pericardium: Structure, foetal development and biochemical properties. Comp Biochem Physiol B, 1989; 94:225–232.
56.
DespresJ-P. Body fat distribution and risk of cardiovascular disease: An update. Circulation, 2012; 126:1301–1313.
57.
JuniP, HolensteinF, SterneJ, et al.Direction and impact of language bias in meta-analyses of controlled trials: Empirical study. Int J Epidemiol, 2002; 31:115–123.
58.
MarwanM, AchenbachS. Quantification of epicardial fat by computed tomography: Why, when and how?. J Cardiovasc Comput Tomogr, 2013; 7:3–10.
59.
NakazatoR, RajaniR, ChengVY, et al.Weight change modulates epicardial fat burden: A 4-year serial study with non-contrast computed tomography. Atherosclerosis., 2012; 220:139–144.
60.
ThanassoulisG, MassaroJM, HoffmannU, et al.Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging, 2010; 3:559–566.
61.
DingJ, HsuFC, HarrisTB, et al.The association of pericardial fat with incident coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr, 2009; 90:499–504.
62.
MazzoccoliG, DagostinoMP, FontanaA, et al.Influence of the Gly1057Asp variant of the insulin receptor substrate 2 (IRS2) on insulin resistance and relationship with epicardial fat thickness in the elderly. Exp Gerontol, 2012; 47:988–993.
63.
ShemiraniH, KhoshaviM. Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease-an observational study. Anadolu Kardiyol Derg, 2012; 12:200–205.
64.
GorterPM, van LindertAS, de VosAM, et al.Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis, 2008; 197:896–903.
